Pediatric immune thrombocytopenia (ITP) is an acquired disorder associated with
autoimmune destruction and impairment of platelet production in children. Some children …

Quantity, quality, and lifespan are 3 important factors in the physiology, pathology, and
transfusion of human blood platelets. The aim of this review is to discuss the proteolytic …

This article summarizes our approach to the management of children and adults with
primary immune thrombocytopenia (ITP) who do not respond to, cannot tolerate, or are …

In 2012, ITP group of Blood Coagulation Abnormalities Research Team with funding from
the Ministry of Health, Labour and Welfare Research Grant for Overcoming Intractable …

With prolonged life expectancy, immune thrombocytopenia (ITP) is frequent in elderly
people. In this setting, ITP diagnosis is challenging because of the concern about an …

Immune thrombocytopenia (ITP) is a rare, acquired autoimmune condition characterized by
a low platelet count and an increased risk of bleeding. Although many children and adults …

In the last decade, rituximab and thrombopoietin-receptor agonists (TPO-ra) have been
introduced into the traditional armamentarium of Immune Thrombocytopenia (ITP) …

Background The optimum second‐line treatment or best sequence of treatments for immune
thrombocytopenia (ITP) are yet to be determined. Our institution has accumulated extensive …

Immune thrombocytopenia (ITP) is a disease in which thrombocytopenia occurs because of
immune-mediated platelet destruction and decreased platelet production. Although many …

Dapsone is recommended as a second line therapy in immune thrombocytopenia (ITP), but
is underused because of its potential side effects. The medical charts of 42 ITP patients …